Eva Renee Barnett
Chief Financial Officer · Immunovant, Inc.
- 2024
- Nov 22, 2024
- 3
Summary
Latest filing:
Eva Renee Barnett is Chief Financial Officer of Immunovant, Inc. (IMVT). 3 SEC Form 4 filings on record, most recently on 22 November 2024. Most recent open-market trade: sold $106K of IMVT on 22 November 2024. Lifetime open-market sales: $353K.
Recent transactions
3The latest 3 SEC Form 4 transactions reported by Eva Renee Barnett.
Trading pattern
InsiderAlpha's records for Eva Renee Barnett go back to 2024: 3 primary Form 4 filings, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Eva Renee Barnett files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Andrew J. Fromkin - $7.96M in IMVT purchases and sales in the last 12 months
- Jay S. Stout - $2.34M in IMVT purchases and sales in the last 12 months
- Melanie Gloria - $1.67M in IMVT purchases and sales in the last 12 months
- Tiago Girao - $1.41M in IMVT purchases and sales in the last 12 months
- Tuyl Christopher van - $1.17M in IMVT purchases and sales in the last 12 months
- Eric Venker - $581K in IMVT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Eva Renee Barnett?
Eva Renee Barnett is a corporate insider, tracked as Chief Financial Officer of Immunovant, Inc. (IMVT). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Eva Renee Barnett last file a Form 4?
The most recent primary Form 4 on record is dated 22 November 2024, one of 3 filings going back to 2024.
Has Eva Renee Barnett been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($353K) across all tracked filings.